Sana Biotechnology Inc.

NASDAQ: SANA · Real-Time Price · USD
3.33
-0.10 (-2.92%)
At close: Aug 15, 2025, 3:59 PM
3.36
0.75%
After-hours: Aug 15, 2025, 07:52 PM EDT

Sana Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 15.28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
2.86M 3.65M 7.64M 4.06M 3.9M 3.75M 7.54M 4.5M 7.85M n/a n/a 7.19M 3.8M 6.22M 5.58M 4.64M n/a n/a
Gross Profit
-2.86M -3.65M 7.64M -4.06M -3.9M -3.75M -7.54M -4.5M -7.85M n/a n/a -7.19M -3.8M -6.22M -5.58M -4.64M -4.05M -3.65M
Operating Income
-94.97M -50.63M -50.87M -61.76M -49.37M -110.72M -90.62M -2.18M -116.29M -84.05M -81.79M -86.19M -72.9M -31.68M -111.28M -83.43M 18.55M -180.75M
Interest Income
577K 992K 1.66M 2.58M 3.2M 3.03M 2.73M 2.86M 2.37M 1.98M 1.61M 1.17M 637K 339K 267K 158K 130K 121K
Pretax Income
-93.8M -49.39M -49.07M -59.92M -50.29M -107.47M -88.12M 984K -114M -82.12M -80.44M -85.12M -72.47M -31.45M -110.73M -83.26M 18.68M -180.62M
Net Income
-93.8M -49.39M -49.07M -59.92M -50.29M -107.47M -88.12M 984K -114M -82.12M -80.44M -85.12M -72.47M -31.45M -110.73M -83.26M 18.68M -180.62M
Selling & General & Admin
10.34M 11.48M 17.28M 14.05M 16.44M 16.27M 20.78M 19.18M 16.57M 16.77M 23.32M 15.51M 18.29M 14.43M 12.68M 13.43M 12.48M 11.82M
Research & Development
29.76M 39.15M 33.59M 47.71M 36.3M 94.45M 69.83M -17M 99.72M 67.29M 58.47M 70.67M 54.61M 17.25M 98.6M 70M -31.03M 168.93M
Other Expenses
1.1M n/a n/a n/a -4.12M 215K -224K 303K -84K n/a n/a -106K 4.5M -102K 281K 10K 1K 13K
Operating Expenses
41.21M 50.63M 50.87M 61.76M 49.37M 110.72M 69.33M 2.18M 116.29M 84.05M 81.79M 86.19M 72.9M 31.68M 111.28M 83.43M -18.55M 180.75M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
44.06M 50.63M 50.87M 61.76M 49.37M 110.72M 76.87M 2.18M 116.29M 84.05M 81.79M 86.19M 72.9M 31.68M 111.28M 83.43M -18.55M 180.75M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -637K -237K n/a -158K -130K -121K
Shares Outstanding (Basic)
238.41M 237.58M 236.3M 235.41M 234.44M 217.29M 197.32M 196.98M 192.54M 191.23M 190.42M 189.3M 187.63M 185.96M 183.99M 181.83M 179.9M 177.61M
Shares Outstanding (Diluted)
238.41M 237.58M 236.3M 235.41M 234.44M 217.29M 197.32M 200.47M 192.54M 191.23M 190.42M 189.3M 187.63M 185.96M 183.99M 181.83M 190.51M 182.91M
EPS (Basic)
-0.39 -0.21 -0.21 -0.25 -0.21 -0.49 -0.45 0.01 -0.59 -0.43 -0.42 -0.45 -0.39 -0.17 -0.6 -0.46 0.10 -1.02
EPS (Diluted)
-0.39 -0.21 -0.21 -0.25 -0.21 -0.49 -0.45 0.00 -0.59 -0.43 -0.42 -0.45 -0.39 -0.17 -0.6 -0.46 0.09 -0.99
EBITDA
-94.97M -46.98M -43.38M -57.7M -45.48M -103.73M -79.36M 2.32M -111.84M -79.71M -77.59M -82.17M -69.1M -28.07M -105.15M -80.55M 21.16M -178.5M
EBIT
-93.8M -50.63M -49.07M -61.53M -50.29M -107.47M -90.62M -2.18M -116.29M -82.12M -80.44M -85.12M -72.9M -31.68M -110.73M -83.26M 18.68M -180.62M
Depreciation & Amortization
2.86M 3.65M 5.69M 4.06M 3.9M 3.75M 11.26M 4.5M 7.85M 7.7M 7.44M 7.19M 3.8M 3.61M 3.33M 4.64M 2.61M 2.25M